marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Poseida Therapeutics Financial Statements 2011-2024 | PSTX
Annual Financial Statements Poseida Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
306 M | 363 M | 424 M | 478 M | - | - | - | - | - | - | - | - | - |
Shares |
90.2 M | 72 M | 62.2 M | 55 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
3.39 | 5.04 | 6.81 | 11 | - | - | - | - | - | - | - | - | - |
Net Income |
-123 M | -64 M | -125 M | -130 M | -86.5 M | -44.4 M | -19.7 M | - | - | - | - | - | - |
Revenue |
64.7 M | 130 M | 31.2 M | - | - | - | 2.98 M | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-130 M | -59.9 M | -141 M | -127 M | -85.5 M | - | - | - | - | - | - | - | - |
Interest Expense |
8.67 M | 6.37 M | 3.36 M | 3.51 M | 3.55 M | - | - | - | - | - | - | - | - |
EBITDA |
-124 M | -54.8 M | -137 M | -124 M | -77.7 M | -38.8 M | -20.9 M | - | - | - | - | - | - |
Operating Expenses |
194 M | 190 M | 173 M | 127 M | 78.8 M | 40.6 M | 24.6 M | - | - | - | - | - | - |
General and Administrative Expenses |
37.4 M | 37.5 M | 35.9 M | 23 M | 18.5 M | 9.67 M | 5.48 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Poseida Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
97.2 M | 97 M | 96 M | 95.6 M | 91.9 M | 86.8 M | 86.3 M | 86 M | 76.3 M | 62.7 M | 62.6 M | 62.5 M | 62.3 M | 62.2 M | 62 M | 61.9 M | 55 M | 13.4 M | 13.3 M | 13.2 M | 12.7 M | 12.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
20.2 M | -31.4 M | -24.3 M | - | -31.8 M | -27.5 M | -38.8 M | - | 70.4 M | -43 M | -58.1 M | - | -42.4 M | -45.7 M | -38.3 M | - | -34.4 M | -30.4 M | -28.8 M | - | -86.5 M | -86.5 M | -13.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
71.7 M | 26 M | 28.1 M | - | 9.35 M | 20 M | 10.3 M | - | 116 M | 2.7 M | 1.44 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
19.7 M | -31.8 M | -24.6 M | - | -36.2 M | -27.9 M | -39.5 M | - | 71.8 M | -41.5 M | -57 M | - | -41.6 M | -44.9 M | -37.5 M | - | -33.5 M | -29.4 M | -28.3 M | - | -20.8 M | -28.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
2.3 M | 2.26 M | 2.25 M | - | 2.24 M | 2.14 M | 2.03 M | - | 1.78 M | -1.54 M | 1.08 M | - | 837 K | 843 K | 838 K | - | 848 K | 892 K | 914 K | - | 935 K | 903 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
21 M | -30.5 M | -23.2 M | - | -34.8 M | -26.5 M | -38.2 M | - | 73.2 M | -40.2 M | -55.8 M | - | -40.4 M | -43.8 M | -36.4 M | - | -32.8 M | -28.9 M | -27.9 M | - | -20 M | -27.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
52 M | 57.7 M | 52.7 M | - | 45.6 M | 47.9 M | 49.9 M | - | 44.5 M | 44.2 M | 58.4 M | - | 41.6 M | 44.9 M | 37.5 M | - | 33.5 M | 29.4 M | 28.3 M | - | 20.8 M | 28.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
10.1 M | 12.2 M | 9.8 M | - | 8.09 M | 8.68 M | 11.8 M | - | 9.39 M | 9.24 M | 9.55 M | - | 9.07 M | 8.87 M | 8.37 M | - | 6.46 M | 4.24 M | 4.85 M | - | 4.01 M | 4.04 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency